Cargando…
Analysis of tumor vascularization in a mouse model of metastatic lung cancer
Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831815/ https://www.ncbi.nlm.nih.gov/pubmed/31690726 http://dx.doi.org/10.1038/s41598-019-52144-2 |
_version_ | 1783466057202139136 |
---|---|
author | Sukhbaatar, Ariunbuyan Sakamoto, Maya Mori, Shiro Kodama, Tetsuya |
author_facet | Sukhbaatar, Ariunbuyan Sakamoto, Maya Mori, Shiro Kodama, Tetsuya |
author_sort | Sukhbaatar, Ariunbuyan |
collection | PubMed |
description | Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of lung metastasis activation, luciferase-expressing tumor cells were inoculated into the subiliac lymph node (SiLN) of an MXH10/Mo-lpr/lpr mouse, and metastatic tumor cells in the lungs were activated by SiLN resection. Activation of metastases was monitored by in vivo bioluminescence imaging. Pulmonary blood vessel characteristics were analyzed using ex vivo micro-computed tomography. The enhanced permeability and retention (EPR) effect in neovasculature after tumor cell activation was evaluated from the accumulation of intravenously injected indocyanine green (ICG) liposomes. Metastatic foci in lung arterioles were investigated histologically. Micro-computed tomography revealed decreases in pulmonary blood vessel length, volume and number of branching nodes during the early stage of metastasis caused by metastatic foci. ICG liposome accumulation by the EPR effect was not detected. Histology identified metastatic foci in lung arterioles. The lack of an EPR effect after the formation of metastatic foci in lung arterioles makes conventional systemic chemotherapy ineffective for lung metastasis. Thus, alternative therapeutic methods of drug delivery are needed. |
format | Online Article Text |
id | pubmed-6831815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68318152019-11-13 Analysis of tumor vascularization in a mouse model of metastatic lung cancer Sukhbaatar, Ariunbuyan Sakamoto, Maya Mori, Shiro Kodama, Tetsuya Sci Rep Article Therapies targeting tumor vasculature would improve the treatment of lung metastasis, although the early changes in vascular structure are incompletely understood. Here, we show that obstructive metastatic foci in lung arterioles decrease the pulmonary vascular network. To generate a mouse model of lung metastasis activation, luciferase-expressing tumor cells were inoculated into the subiliac lymph node (SiLN) of an MXH10/Mo-lpr/lpr mouse, and metastatic tumor cells in the lungs were activated by SiLN resection. Activation of metastases was monitored by in vivo bioluminescence imaging. Pulmonary blood vessel characteristics were analyzed using ex vivo micro-computed tomography. The enhanced permeability and retention (EPR) effect in neovasculature after tumor cell activation was evaluated from the accumulation of intravenously injected indocyanine green (ICG) liposomes. Metastatic foci in lung arterioles were investigated histologically. Micro-computed tomography revealed decreases in pulmonary blood vessel length, volume and number of branching nodes during the early stage of metastasis caused by metastatic foci. ICG liposome accumulation by the EPR effect was not detected. Histology identified metastatic foci in lung arterioles. The lack of an EPR effect after the formation of metastatic foci in lung arterioles makes conventional systemic chemotherapy ineffective for lung metastasis. Thus, alternative therapeutic methods of drug delivery are needed. Nature Publishing Group UK 2019-11-05 /pmc/articles/PMC6831815/ /pubmed/31690726 http://dx.doi.org/10.1038/s41598-019-52144-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Sukhbaatar, Ariunbuyan Sakamoto, Maya Mori, Shiro Kodama, Tetsuya Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title | Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title_full | Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title_fullStr | Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title_full_unstemmed | Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title_short | Analysis of tumor vascularization in a mouse model of metastatic lung cancer |
title_sort | analysis of tumor vascularization in a mouse model of metastatic lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831815/ https://www.ncbi.nlm.nih.gov/pubmed/31690726 http://dx.doi.org/10.1038/s41598-019-52144-2 |
work_keys_str_mv | AT sukhbaatarariunbuyan analysisoftumorvascularizationinamousemodelofmetastaticlungcancer AT sakamotomaya analysisoftumorvascularizationinamousemodelofmetastaticlungcancer AT morishiro analysisoftumorvascularizationinamousemodelofmetastaticlungcancer AT kodamatetsuya analysisoftumorvascularizationinamousemodelofmetastaticlungcancer |